Viswanathan Pragasam
University of Madras
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Viswanathan Pragasam.
Clinical Chemistry and Laboratory Medicine | 2005
Periandavan Kalaiselvi; Viswanathan Pragasam; Srinivasan Chinnikrishnan; Coothan Kandaswamy Veena; Rajaguru Sundarapandiyan; Palaninathan Varalakshmi
Abstract Adriamycin (ADR), a cytotoxic antineoplastic drug, is used in the treatment of various solid tumors. However, its efficacy continues to be challenged by significant toxicities including nephrotoxicity. In the present study, the effects of N-acetyl cysteine (NAC) and vitamin E, known antioxidants, were investigated on ADR-induced peroxidative damage in rat kidney. Adult male albino rats of Wistar strain were administered ADR as a single dose (10mg/kg body weight, i.v.). Histopathological studies indicated that ADR-treated kidney sections show focal tubular necrosis and casts. ADR-injected rats showed a significant decline in the activities/levels of enzymic antioxidants (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glucose-6-phosphate dehydrogenase and glutathione-S-transferase) and non-enzymic antioxidants (thiols, vitamin C and vitamin E) with high malondialdehyde levels. The extent of nephrotoxicity was evident from the increased activities of urinary marker enzymes (alkaline phosphatase, lactate dehydrogenase and γ-glutamyltransferase). Treatment with NAC and vitamin E (50mg/kg b.w., i.p.) 1day prior to ADR administration maintained near normal activities of the enzymes, significantly reduced lipid peroxidation and prevented the necrosis caused by ADR, thereby proving to be an effective thiol replenishing agent and antioxidant.
Nephron Physiology | 2004
Viswanathan Pragasam; Periandavan Kalaiselvi; Balasubramanian Subashini; Kamalanathan Sumitra; Palaninathan Varalakshmi
Objective: The crucial steps involved in the lithogenic process are governed by the macromolecular components of urine, of which proteins play a major role. Structurally abnormal proteins have been reported to be present in the urine of stone formers. Free radical injury has come a long way in explaining some of the pathophysiological events of renal lithiasis. Thus, our present work was designed to study the impact of the potent oxidant peroxynitrite on the biochemical components of the urinary Tamm-Horsfall glycoprotein (THP). Materials and Methods: Nitration on THP was carried out using peroxynitrite (ONOO–). After nitration, biochemical components like thiols, S-nitrosothiol, hexose, hexosamine and sialic acid were determined and these factors were compared with those of stone formers and normal THP. Crystallization behavior of control, nitrated NS-THP and stone formers THP was studied. Results: There was a significant decrease in thiol, hexose, hexosamine and sialic acid contents in stone formers and nitrated NS-THP, when compared to that of the control THP. In contrast to this, S-nitrosothiol content was significantly increased in stone formers and nitrated NS-THP (p < 0.001) when compared with the control THP. NOx metabolites were significantly elevated in stone formers THP when compared with that of control THP. When subjected to CaOx crystallization, stone formers THP and nitrated NS-THP promoted both CaOx nucleation and aggregation, while normal THP was found to be an inhibitor of the above processes. Conclusion: From our results we conclude that nitration of THP could represent one of the prime events in modifying kinetic behavior of THP, thus converting THP into a heterogeneous nucleator of renal calculi formation.
Biomarkers | 2006
Viswanathan Pragasam; Periandavan Kalaiselvi; Kamalanathan Sumitra; S. Srinivasan; P. Anandkumar; Palaninathan Varalakshmi
Abstract The generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in hyperoxaluric condition has been proved experimentally. This may result in the formation of the cytotoxic metabolite peroxynitrite, which is capable of causing lipid peroxidation and protein modification. The presence of nitrotyrosine in proteins has been associated with several pathological conditions. The present study investigated the presence of nitrotyrosine in the stone formers Tamm–Horsfall glycoprotein (THP). In vitro nitration of control THP was carried out using peroxynitrite. New Zealand white rabbits were immunized with peroxynitrated THP at 15-day intervals. Antisera collected following the third immunization were assayed for antibody titres using solid-phase ELISA. Antibodies were purified by affinity chromatography. The carbonyl content of control, stone formers and nitrated THP were determined. Western blotting was carried with control, stone formers and nitrated THPs. Immunodiffusion studies demonstrated cross-reaction with nitrated bovine serum albumin. Significant amounts (p<0.001) of carbonyl content were present in both stone formers and nitrated THPs. Western blot analysis confirmed the presence of nitrated amino acid 3-nitrotyrosine in stone formers, which could bring about structural and functional modifications of THP in hyperoxaluric patients. A cross-reaction with nitrated bovine serum albumin confirms that the raised antibody has certain paratopes similar to the epitope of nitrated protein molecules. Detection of 3-nitrotyrosine in stone formers THP indicates that it is one of the key factors influencing the conversion of THP to a structurally and immunologically altered form during calcium oxalate stone formation.
Nephrology Dialysis Transplantation | 2005
Kamalanathan Sumitra; Viswanathan Pragasam; Ramasamy Sakthivel; Periandavan Kalaiselvi; Palaninathan Varalakshmi
Clinica Chimica Acta | 2005
Viswanathan Pragasam; Periandavan Kalaiselvi; Kamalanathan Sumitra; Shunmugarajan Srinivasan; Palaninathan Varalakshmi
Clinica Chimica Acta | 2004
S. Srinivasan; Viswanathan Pragasam; X. Jenita; Periandavan Kalaiselvi; V. Muthu; Palaninathan Varalakshmi
Clinica Chimica Acta | 2005
S. Srinivasan; Periandavan Kalaiselvi; Ramasamy Sakthivel; Viswanathan Pragasam; V. Muthu; Palaninathan Varalakshmi
Clinica Chimica Acta | 2005
Viswanathan Pragasam; Periandavan Kalaiselvi; Kamalanathan Sumitra; Shanmugarajan Srinivasan; Palaninathan Varalakshmi
Urological Research | 2005
Viswanathan Pragasam; Ramasamy Sakthivel; Periyandavan Kalaiselvi; Nachiappa Ganesh Rajesh; Palaninathan Varalakshmi
International Journal of Medical Science and Public Health | 2013
Thomas Michael Shiju; Madathil Deepa; Viswanathan Pragasam